These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30400100)

  • 1. Diazepam Toxicity Presenting as a Dementia Disorder.
    Kurlawala Z; Roberts JA; McMillan JD; Friedland RP
    J Alzheimers Dis; 2018; 66(3):935-938. PubMed ID: 30400100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine use and cognitive decline in the elderly.
    Picton JD; Marino AB; Nealy KL
    Am J Health Syst Pharm; 2018 Jan; 75(1):e6-e12. PubMed ID: 29273607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study.
    Gray SL; Dublin S; Yu O; Walker R; Anderson M; Hubbard RA; Crane PK; Larson EB
    BMJ; 2016 Feb; 352():i90. PubMed ID: 26837813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective action of diazepam at very low and moderate doses in Alzheimer's disease model rats.
    Pilipenko V; Narbute K; Pupure J; Rumaks J; Jansone B; Klusa V
    Neuropharmacology; 2019 Jan; 144():319-326. PubMed ID: 30408486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzodiazepine use and risk of Alzheimer's disease: case-control study.
    Billioti de Gage S; Moride Y; Ducruet T; Kurth T; Verdoux H; Tournier M; Pariente A; Bégaud B
    BMJ; 2014 Sep; 349():g5205. PubMed ID: 25208536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive differential diagnosis of dementing diseases: Alzheimer's Dementia, Vascular Dementia, Frontotemporal Dementia, and Major Depressive Disorder.
    Braaten AJ; Parsons TD; McCue R; Sellers A; Burns WJ
    Int J Neurosci; 2006 Nov; 116(11):1271-93. PubMed ID: 17000529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease.
    Saarelainen L; Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
    J Alzheimers Dis; 2016; 49(3):809-18. PubMed ID: 26484930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memory function and the clinical differentiation of dementing disorder.
    Shuttleworth EC
    J Am Geriatr Soc; 1982 Jun; 30(6):363-6. PubMed ID: 7077015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between benzodiazepines use and falls in the elderly: a multicenter study in three geriatric centers of a university hospital].
    Uhart M; Odouard E; Carlier C; Maire P; Ducher M; Bourguignon L
    Ann Pharm Fr; 2012 Jan; 70(1):46-52. PubMed ID: 22341008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. It's not all Alzheimer's. Sorting out cognitive changes.
    Mayo Clin Health Lett; 2010 Jul; 28(7):1-3. PubMed ID: 20799377
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-induced cerebral glucose metabolism resembling Alzheimer's Disease: a case study.
    Riepe MW; Walther B; Vonend C; Beer AJ
    BMC Psychiatry; 2015 Jul; 15():157. PubMed ID: 26163145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between memory complaints and incident Alzheimer's disease in elderly people with normal baseline cognition.
    Geerlings MI; Jonker C; Bouter LM; Adèr HJ; Schmand B
    Am J Psychiatry; 1999 Apr; 156(4):531-7. PubMed ID: 10200730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzodiazepine Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis.
    Imfeld P; Bodmer M; Jick SS; Meier CR
    Drug Saf; 2015 Oct; 38(10):909-19. PubMed ID: 26123874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation.
    Rickels K; Schweizer E; Case WG; Greenblatt DJ
    Arch Gen Psychiatry; 1990 Oct; 47(10):899-907. PubMed ID: 2222129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
    Löscher W; Hönack D
    Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic use of benzodiazepines and psychomotor and cognitive test performance.
    Lucki I; Rickels K; Geller AM
    Psychopharmacology (Berl); 1986; 88(4):426-33. PubMed ID: 2871579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of Alzheimer's disease associated with benzodiazepines and related drugs: a nested case-control study.
    Tapiainen V; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
    Acta Psychiatr Scand; 2018 Aug; 138(2):91-100. PubMed ID: 29851063
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.